{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:18:04Z","timestamp":1792027084256,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec030\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute Myeloid Leukemia (AML) exhibits significant heterogeneity in clinical outcomes, yet current prognostic stratification systems based on genetic alterations alone cannot fully capture this complexity. This study aimed to develop an integrated epigenetic-based classification system and evaluate its prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec031\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed multi-omics analysis on five independent cohorts totaling 1,103 AML patients. The Cancer Genome Atlas-Acute Myeloid Leukemia (TCGA-LAML) cohort (n\u2009=\u200983) provided comprehensive multi-omics data including DNA methylation profiles (Illumina 450K platform), RNA sequencing (mRNA, lncRNA, and miRNA), and somatic mutation profiles. The BEAT (n\u2009=\u2009649), TARGET (n\u2009=\u2009156), GSE12417 (n\u2009=\u200979), and GSE37642 (n\u2009=\u2009136) cohorts contributed transcriptome data. Molecular subtypes were identified using empirical Bayes-based clustering on the TCGA cohort. LSC17 scores were calculated using a validated 17-gene expression signature. A random survival forest model was developed integrating molecular features with LSC17 scores, validated across all cohorts. Immune microenvironment analysis employed multiple deconvolution methods (ESTIMATE, CIBERSORT, xCell) and pathway analysis (GSVA, GSEA). Drug sensitivity was predicted using the pRRophetic algorithm with GDSC database reference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec032\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multi-omics integration revealed two molecularly distinct AML subtypes with significant survival differences (CS2 vs CS1, P\u2009&lt;\u20090.001). The random survival forest model, incorporating 20 key epigenetic features (including CPNE8, CD109, and CHRDL1) and LSC17 scores, achieved superior prognostic accuracy (C-index: 0.72\u20130.78) across validation cohorts. Both epigenetic risk score (HR\u2009=\u20092.45, 95%CI: 1.86\u20133.24) and LSC17 score (HR\u2009=\u20091.89, 95%CI: 1.42\u20132.51) maintained independent prognostic value in multivariate analysis. Integration of both scores in a nomogram improved 1-, 3-, and 5-year survival predictions (C-index: 0.81). High-risk patients exhibited distinct immune profiles with elevated M2 macrophages (1.8-fold) and Tregs (2.3-fold), while low-risk patients showed enhanced NK cell activity (2.1-fold). Drug sensitivity analysis identified differential responses to epigenetic regulators (LAQ824, P\u2009=\u20090.000139; MS-275, P\u2009=\u20090.00104) and proteasome inhibitors (Bortezomib, P\u2009=\u20090.00747; MG-132, P\u2009=\u20090.0106) between risk groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec033\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This integrated classification system combining epigenetic features and stem cell signatures provides new insights into AML heterogeneity and therapeutic targeting. The complementary nature of epigenetic and stem cell-related prognostic factors suggests potential for improved risk stratification in clinical practice. Future prospective validation studies are warranted to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0324380","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:35:33Z","timestamp":1748439333000},"page":"e0324380","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Integrative analysis of epigenetic subtypes in acute myeloid Leukemia: A multi-center study combining machine learning for prognostic and therapeutic insights"],"prefix":"10.1371","volume":"20","author":[{"given":"Jincan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6026-5366","authenticated-orcid":true,"given":"Shengyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"3","key":"pone.0324380.ref001","first-page":"38","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"A Pelcovits","year":"2020","journal-title":"R I Med J"},{"issue":"9","key":"pone.0324380.ref002","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"B Deschler","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"pone.0324380.ref003","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.26079","article-title":"Determination of fitness and therapeutic options in older patients with acute myeloid leukemia","volume":"96","author":"JE Cortes","year":"2021","journal-title":"Am J Hematol"},{"issue":"1","key":"pone.0324380.ref004","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12943-023-01889-6","article-title":"Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy","volume":"22","author":"T Sauerer","year":"2023","journal-title":"Mol Cancer"},{"issue":"18","key":"pone.0324380.ref005","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.3390\/ijms20184576","article-title":"Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications","volume":"20","author":"X Yang","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0324380.ref006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-020-00674-7","article-title":"Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies","volume":"27","author":"H-A Hou","year":"2020","journal-title":"J Biomed Sci"},{"issue":"3","key":"pone.0324380.ref007","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.seminhematol.2015.04.003","article-title":"Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions","volume":"52","author":"TK Kim","year":"2015","journal-title":"Semin Hematol"},{"issue":"2","key":"pone.0324380.ref008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOH.0000000000000567","article-title":"Driver mutations in acute myeloid leukemia","volume":"27","author":"A Kishtagari","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"pone.0324380.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2022.03.003","article-title":"Epigenetic maintenance strategies after allogeneic stem cell transplantation in acute myeloid leukemia","volume":"109","author":"Y Yan","year":"2022","journal-title":"Exp Hematol"},{"issue":"1","key":"pone.0324380.ref010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","article-title":"Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies","volume":"8","author":"A Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"pone.0324380.ref011","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fonc.2019.01048","article-title":"Long Non-coding RNAs in Myeloid Malignancies","volume":"9","author":"A-A Zimta","year":"2019","journal-title":"Front Oncol"},{"issue":"3","key":"pone.0324380.ref012","first-page":"799","article-title":"Role of microRNAs in leukemia stem cells","volume":"4","author":"J Huang","year":"2012","journal-title":"Front Biosci (Schol Ed)"},{"issue":"4","key":"pone.0324380.ref013","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s13353-011-0057-x","article-title":"Sequencing technologies and genome sequencing","volume":"52","author":"CS Pareek","year":"2011","journal-title":"J Appl Genet"},{"issue":"2","key":"pone.0324380.ref014","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2022.280800","article-title":"Leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"108","author":"P Stelmach","year":"2023","journal-title":"Haematologica"},{"issue":"7728","key":"pone.0324380.ref015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"JW Tyner","year":"2018","journal-title":"Nature"},{"key":"pone.0324380.ref016","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bav067","article-title":"EpiFactors: a comprehensive database of human epigenetic factors and complexes","volume":"2015","author":"YA Medvedeva","year":"2015","journal-title":"Database (Oxford)"},{"issue":"11","key":"pone.0324380.ref017","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"A Mayakonda","year":"2018","journal-title":"Genome Res"},{"issue":"1","key":"pone.0324380.ref018","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"WE Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"pone.0324380.ref019","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","article-title":"MOVICS: an R package for multi-omics integration and visualization in cancer subtyping","volume":"36","author":"X Lu","year":"2020","journal-title":"Bioinformatics"},{"key":"pone.0324380.ref020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"S H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"21","key":"pone.0324380.ref021","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1093\/bioinformatics\/btz229","article-title":"RTNsurvival: an R\/Bioconductor package for regulatory network survival analysis","volume":"35","author":"CS Groeneveld","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"pone.0324380.ref022","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00432-022-04566-1","article-title":"Genome-wide DNA methylation profile analysis identifies an individualized predictive signature for melanoma immune response","volume":"149","author":"J Yan","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"pone.0324380.ref023","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"K Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"pone.0324380.ref024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT","volume":"1711","author":"B Chen","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"1","key":"pone.0324380.ref025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","article-title":"Random Forest","volume":"47","author":"SJ Rigatti","year":"2017","journal-title":"J Insur Med"},{"key":"pone.0324380.ref026","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/978-1-62703-017-5_23","article-title":"Elastic network models: theoretical and empirical foundations","volume":"924","author":"Y-H Sanejouand","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"2","key":"pone.0324380.ref027","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00180-015-0642-2","article-title":"Boosting in Cox regression: a comparison between the likelihood-based and the model-based approaches with focus on the R-packages CoxBoost and mboost","volume":"31","author":"R De Bin","year":"2016","journal-title":"Comput Stat"},{"key":"pone.0324380.ref028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnbot.2013.00021","article-title":"Gradient boosting machines, a tutorial","volume":"7","author":"A Natekin","year":"2013","journal-title":"Front Neurorobot"},{"key":"pone.0324380.ref029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12874-015-0009-y","article-title":"Optimal cut-point definition in biomarkers: the case of censored failure time outcome","volume":"15","author":"M Rota","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"pone.0324380.ref030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"A Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"pone.0324380.ref031","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","article-title":"EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data","volume":"2120","author":"J Racle","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"1","key":"pone.0324380.ref032","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13059-016-1113-y","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression [published correction appears in","volume":"17","author":"E Becht","year":"2016","journal-title":"Genome Biol"},{"issue":"1","key":"pone.0324380.ref033","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"D Aran","year":"2017","journal-title":"Genome Biol"},{"issue":"21","key":"pone.0324380.ref034","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"T Li","year":"2017","journal-title":"Cancer Res"},{"key":"pone.0324380.ref035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.mie.2019.05.056","article-title":"Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq","volume":"636","author":"C Plattner","year":"2020","journal-title":"Methods Enzymol"},{"issue":"9","key":"pone.0324380.ref036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"P Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"pone.0324380.ref037","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"pone.0324380.ref038","article-title":"ABC portal: a single-cell database and web server for blood cells","volume":"51","author":"X Gao","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0324380.ref039","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1038\/s41467-022-31995-w","article-title":"Author Correction: A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing","volume":"13","author":"AA Petti","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"pone.0324380.ref040","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"JD Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"pone.0324380.ref041","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41576-021-00438-5","article-title":"Molecular mechanisms of transgenerational epigenetic inheritance","volume":"23","author":"MH Fitz-James","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"7633","key":"pone.0324380.ref042","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"SWK Ng","year":"2016","journal-title":"Nature"},{"issue":"23","key":"pone.0324380.ref043","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"E Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0324380.ref044","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1038\/s41598-021-84514-0","article-title":"Bayesian network-driven clustering analysis with feature selection for high-dimensional multi-modal molecular data","volume":"11","author":"Y Zhao","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0324380.ref045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-020-00941-y","article-title":"A single-cell survey of cellular hierarchy in acute myeloid leukemia","volume":"13","author":"J Wu","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"4","key":"pone.0324380.ref046","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood.2021014670","article-title":"Single-cell genomics in AML: extending the frontiers of AML research","volume":"141","author":"A Ediriwickrema","year":"2023","journal-title":"Blood"},{"issue":"1","key":"pone.0324380.ref047","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"B Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"pone.0324380.ref048","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"L Chiossone","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"pone.0324380.ref049","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41408-024-01103-w","article-title":"Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia","volume":"14","author":"Y Yao","year":"2024","journal-title":"Blood Cancer J"},{"issue":"11","key":"pone.0324380.ref050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1182\/blood.2019003339","article-title":"Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis","volume":"135","author":"MF Bezerra","year":"2020","journal-title":"Blood"},{"issue":"7","key":"pone.0324380.ref051","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1172\/JCI85736","article-title":"Differential requirements for myeloid leukemia IFN-\u03b3 conditioning determine graft-versus-leukemia resistance and sensitivity","volume":"127","author":"C Matte-Martone","year":"2017","journal-title":"J Clin Invest"},{"issue":"21","key":"pone.0324380.ref052","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-12-3629","article-title":"Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer","volume":"19","author":"B Li","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"3","key":"pone.0324380.ref053","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12016-016-8534-y","article-title":"Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review","volume":"50","author":"H Wu","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"pone.0324380.ref054","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/cells12020322","article-title":"Novel Insights into the Role of Kras in Myeloid Differentiation: Engaging with Wnt\/\u03b2-Catenin Signaling","volume":"12","author":"N Yokoyama","year":"2023","journal-title":"Cells"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:35:47Z","timestamp":1748439347000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324380"}},"subtitle":[],"editor":[{"given":"Jian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0324380","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}